Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects

NCT07584304 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: YHP2508C
DRUG: YHR2603

Sponsor

Yuhan Corporation